Published Online: Monday, January 1, 2007

Chain drugstore industry leaders are warning Congress that, instead of improving patient knowledge about prescription drugs, overuse of FDA patient medication guides could have the opposite effect.

In a statement to the Senate Health, Education, Labor and Pensions Committee, the National Association of Chain Drug Stores (NACDS) expressed concern about proposals that "could lead to the unnecessary approval of MedGuides outside the scope of the FDA's original intention to require them only for a few products which pose a ‘serious or significant concern.'"

Already >1500 individual drug products must be dispensed with MedGuides. Arguing that FDA-required MedGuides may not be the most effective way to educate patients for all medications, NACDS said that these pamphlets "should remain a resource only for medications which pose a serious or significant concern."

Latest Articles
Having trouble getting your hands on FluMist?
Novartis is paying $390 million to settle charges that it paid kickbacks to pharmacies to encourage drug sales.
Anxiety sensitivity has been linked to more debilitating asthma symptoms and greater functional limitations.
Nasal corticosteroid sprays do not seem to be viable treatments for the common cold.
Latest Issues